Search Results
17 items found for "A Reum Je"
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
December 2021 OMass Therapeutics 's founder, Carol Robinson , has been awarded the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry " Huge congratulations to our founder, Carol Robinson , who has been awarded the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry
- Oxford Professor Of Chemistry And Founder Of Therapeutic Company Wins Two International Awards
consultant to) OMass Therapeutics , which is based at Oxford Science Park, has been awarded the 2022 Louis-Jeantet
- Therapeutic validation of an orphan G protein‐coupled receptor
renders it a promising target in inflammatory and fibrotic conditions, including neuroinflammation (Audoy‐Remus GPR84 involvement in pain, atherosclerosis, and even metabolic disorders (Nicol et al., 2015, Audoy‐Remus
- 📰 GPCR Weekly News, February 5 to 11, 2024
If you are interested in applying, please email us your CV/Resume at Hello@DrGPCR.com. Dr.
- 📰 GPCR Weekly News, February 12 to 18, 2024
If you are interested in applying, please email us your CV/Resume at Hello@DrGPCR.com. Dr.
- 📰 GPCR Weekly News, January 22 to 28, 2024
If you are interested in applying, please email us your CV/Resume at Hello@DrGPCR.com. Dr.
- 📰 GPCR Weekly News, December 11 to 17, 2023
We'll pause our regular updates during this time and will resume our newsletter in the upcoming year
- 📰 GPCR Weekly News, February 19 to 25, 2024
If you are interested in applying, please email us your CV/Resume at Hello@DrGPCR.com. Dr.
- 📰 GPCR Weekly News, January 29 to February 4, 2024
If you are interested in applying, please email us your CV/Resume at Hello@DrGPCR.com. Dr.
- 📰 GPCR Weekly News, June 24 to 30, 2024
Kawthar Belkacemi , Philippe Rondard , Jean-Philippe Pin , and Laurent Prézeau , for their research
- 📰 GPCR Weekly News, May 27 to June 2, 2024
., as Senior Vice President of Medical Affairs Septerna to Participate in the Jefferies Global Healthcare
- 📰 GPCR Weekly News, November 6 to November 12, 2023
Third Quarter 2023 Addex CEO Tim Dyer to Discuss Allosteric Modulators in Neurological Disorders at Jefferies
- 📰 GPCR Weekly News, May 29 to June 4, 2023
Nomination of DT-9045: A Groundbreaking NAM for Immunooncology Structure Therapeutics to Present at Jefferies
- 📰 GPCR Weekly News, May 8 to 14, 2023
Recommends Continuing Study Addex Therapeutics in the 23rd BioEquity Europe Conference Simon Bekker-Jensen
- 📰 GPCR Weekly News, April 24 to 30, 2023
A visual opsin from jellyfish enables precise temporal control of G protein signalling.
- 📰 GPCR Weekly News, April 3 to 9, 2023
landscape tampering in lung fibroblasts. βHB inhibits glucose-induced GLP-1 secretion in GLUTag and human jejunal
- The Bile Acid Membrane Receptor TGR5 in Cancer: Friend or Foe?
TGR5 is widely distributed in the brain, lung, heart, liver, spleen, pancreas, kidney, stomach, jejunum